AKBA Operating Income Growth
Akebia Therapeutics Inc · Operating Income Growth
AKBA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-2012.26%period ending
AKBA TTM Operating Income YoY % (-189.21% → -2012.26%)
Year-over-year change
High-resolution chart · PNG
AKBA operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -2,012.263% | |
| 124.0158% | |
| 146.5576% | |
| 151.0031% | |
| 102.2393% | |
| 38.1272% | |
| -9.119% | |
| 35.5453% | |
| 61.3314% | |
| 26.2713% | |
| 43.0168% | |
| 61.4881% | |
| 36.8459% | |
| 81.2923% | |
| 69.311% | |
| 50.7453% | |
| 49.7375% | |
| 32.49% | |
| 29.7363% | |
| 26.2649% | |
| 25.0078% | |
| -41.8673% | |
| -31.4907% | |
| -37.0816% | |
| -51.394% | |
| -17.3485% | |
| -60.7105% | |
| -267.3639% | |
| -247.3681% | |
| -286.2692% | |
| -122.905% | |
| 40.7429% | |
| 48.3712% | |
| 61.7449% | |
| 41.4356% | |
| -9.1689% | |
| -38.6144% | |
| -102.6871% | |
| -121.8393% | |
| -127.513% | |
| -142.9055% | |
| -96.9404% | |
| -62.1313% | |
| -55.2731% | |
| -49.9975% | |
| -67.3182% | |
| -138.1278% | |
| -189.2055% |